CPX: Began Phase II testing

SciClone Pharmaceuticals Inc. (SCLN), San Mateo, Calif. Product: CPX Business: Pulmonary Therapeutic category: Ion channel modulation Target: CFTR Description: Oral compound that promotes trafficking...